Further, we suggest a possible role of tumor-expressed FcRI in complementing the metastatic phenotype - Current concepts in The identification and characterisation of Rho Kinase Inhibitors

Further, we suggest a possible role of tumor-expressed FcRI in complementing the metastatic phenotype

Further, we suggest a possible role of tumor-expressed FcRI in complementing the metastatic phenotype. Open in a separate window Figure 6 Model of specific Ab-tumor cell promotion. kinase signal transduction pathway. A selective inhibitor of phosphatidylinositol-3 kinase also inhibited this induction of tumor cell proliferation. These findings support a role for immune complexes and FcRI … Continue reading Further, we suggest a possible role of tumor-expressed FcRI in complementing the metastatic phenotype